相关实验视频

Updated: Jul 21, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

在阻止疟疾传播的疫苗中评估不同类型的辅助剂

Xinxin Yu¹, Hui Min¹, Shijie Yao¹

¹Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, China.

International immunopharmacology

|March 9, 2024

概括

疟疾传播阻断疫苗候选人P. berghei ookinete表面抗原PSOP25,当配合细胞氨酸酸酸寡氧核化物 (CpG) 辅助剂时,与其他测试辅助剂相比,显示出优异的免疫反应和传播阻断活性. 这种CpG辅助剂的疫苗显示出增强疟疾控制的前景.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
寄生虫学的寄生虫学

背景情况:

辅助剂对于疫苗的有效性至关重要,增强免疫反应.
有限的研究存在于疟疾传播阻断疫苗 (TBV) 的辅助剂.
贝尔盖也具有表面抗原PSOP25,是一个有前途的TBV候选者.

研究的目的:

为了评估与各种辅助剂配制的PSOP25的免疫性和疗效.
确定最佳的辅助剂,以增强疟疾传播阻断活性.
研究不同辅助剂组合诱导的免疫机制.

主要方法:

rPSOP25与辅助剂的配方:单酸脂A (MPLA),CpG ODN 1826 (CpG),QS-21,氧化 (Alum) 和组合 (MPLA+QS-21,QS-21+CpG). rPSOP25与辅助剂的配方:单酸脂A (MPLA),CpG ODN 1826 (CpG),QS-21,氧化 (Alum),以及组合 (MPLA+QS-21,QS-21+CpG). rPSOP25与辅助剂的配方:单酸脂A (MPLA),CpG ODN 1826 (CpG),QS-21,氧化 (Alum),以及组合 (MPLA+QS-21,QS-21+CpG).
评估抗体水平,血细胞增殖,生殖中心形成和树突细胞激活.
评估传输阻断活性,免疫记忆,Th1反应和Tfh细胞群.

主要成果:

辅助疫苗增强了抗体水平,血细胞的增殖和生殖中心的形成.
CpG辅助剂表现出最强烈的抑制 ookinete 形成和传输阻断活性.
CpG辅助剂有效地激活了树突细胞,并引起了强大的免疫记忆,Th1反应和Tfh细胞群.

结论:

CpG辅助剂显著提高了rPSOP25疟疾传播阻断疫苗的疗效.
将rPSOP25与CpG结合使用会引起保护性免疫反应,并改善传播阻断活性.
CpG辅助剂是开发有效的疟疾TBV的有希望的候选者.

关键词:

一个辅助的辅助.在CpG ODN中使用.在MPLA中,MPLA就是一个MPLA.疟疾:疟疾是一种疾病.在QS-21中,它是QS-21.这种疫苗是传播阻断疫苗.

更多相关视频

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

相关概念视频

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Poliomyelitis

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...